TipRanks
Go Ultimate55% OFF

NeoPharm Co., Ltd. (092730) Balance Sheet

NeoPharm Co., Ltd. Balance Sheet

NeoPharm Co., Ltd.'s total assets for Q1 2026 were $225.35B, an increase of 2.30% from the previous quarter. KR:092730 total liabilities were $33.24B for the fiscal quarter, a 33.41% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 220.28B$ 192.44B$ 177.46B$ 155.35B$ 143.41B
$ 24.92B$ 15.56B$ 17.43B$ 13.14B$ 13.10B
$ 195.36B$ 176.88B$ 160.03B$ 142.21B$ 130.30B

Currency in KRW

NeoPharm Co., Ltd. Debt to Assets

080B160B240B5 %10 %15 %20 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets